3Coleston DM,Hindmarch I.Possible memory-enhancing properties of vinpocetine〔J〕. Drug Development Research . 1988
4Schmidt J,Wustmann C,Rudolph E,et al.Effect of nootropic drugs on age dependent changes in transmitter release〔J〕. Drug Development Research . 1988
5Hindmarch I,Fuchs HH,Erzigkeit H.Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes〔J〕. International Clinical Psychopharmacology . 1991
6Slepova OS,Kushnir VN,Zaitseva NS,et al.Clinical and immunological signs of retinal involvement and potentialities off its drug correction in patients with chronic diffuse viral diseases of the liver and in Australian antigen carriers〔J〕. Vestnik Oftalmologii . 1994
7Gulyas B,Halldin C,Karlsson P,et al.Brain uptake and plasma metabolism of 〔11 C〕vinpocetine: a preliminary PET study in a cynomolgus monkey〔J〕. Journal of Neuroimaging . 1999
8Kahan A,Olah M.Use of ethyl apovincaminate in ophthalmological therapy〔J〕. Arzneim Forsch Drug Research . 1976
9Manconi E,Binaghi F,Pitzus F.A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin〔J〕. Current Therapeutic Research . 1986
10Miskolczi P,Kozma K,Polgar M,et al.Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans〔J〕. European Journal of Drug Metabolism and Pharmacokinetics . 1990
